Home › Trial NCT02376127
Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion
- Trial IDNCT02376127
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorMemorial Sloan Kettering Cancer Center
- Enrollment25
- Start date2015-02-24
- ConditionsSolid Cancer · Metastatic Spinal Lesions
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.